sublocade
Generic: buprenorphine
Labeler: indivior inc.Drug Facts
Product Profile
Brand Name
sublocade
Generic Name
buprenorphine
Labeler
indivior inc.
Dosage Form
SOLUTION
Routes
Active Ingredients
buprenorphine 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
12496-0300
Product ID
12496-0300_a5971cb4-0e84-4bc6-a2ff-bbd668f2dbec
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA209819
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2018-02-26
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
124960300
Hyphenated Format
12496-0300
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sublocade (source: ndc)
Generic Name
buprenorphine (source: ndc)
Application Number
NDA209819 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 1 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (12496-0300-2) / 1 SOLUTION in 1 SYRINGE (12496-0300-5)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "a5971cb4-0e84-4bc6-a2ff-bbd668f2dbec", "openfda": {"nui": ["N0000175689", "N0000175685"], "upc": ["0312496030011"], "unii": ["40D3SCR4GZ"], "rxcui": ["1996184", "1996189", "1996192", "1996193"], "spl_set_id": ["6189fb21-9432-45f8-8481-0bfaf3ccde95"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]"], "manufacturer_name": ["Indivior Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (12496-0300-2) / 1 SOLUTION in 1 SYRINGE (12496-0300-5)", "package_ndc": "12496-0300-1", "marketing_start_date": "20180226"}], "brand_name": "SUBLOCADE", "product_id": "12496-0300_a5971cb4-0e84-4bc6-a2ff-bbd668f2dbec", "dosage_form": "SOLUTION", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "12496-0300", "dea_schedule": "CIII", "generic_name": "buprenorphine", "labeler_name": "Indivior Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SUBLOCADE", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "300 mg/1"}], "application_number": "NDA209819", "marketing_category": "NDA", "marketing_start_date": "20180226", "listing_expiration_date": "20271231"}